Myelodysplastic syndrome in elderly patients: Correlation of CBC with cytogenetic and FISH analysis

International Journal of Laboratory Hematology

Volumn 32, Issue 4, 2010, Pages 443-448

  Codispoti, K E T ^a   Depalma, L ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Anemia of elderly; FISH; MDS

Indexed keywords

HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CHROMOSOME ABERRATION; CYTOGENETICS; ELDERLY CARE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANEMIA; BLOOD CELL COUNT; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MYELODYSPLASTIC SYNDROMES;

EID: 77957968415     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01210.x     Document Type: Article

References (17)

1. Bernasconi P., Cavigliano P. M., Boni M., Calatroni S., Klersy C., Giardini I., Rocca B., Crosetto N., Caresana M., Lazzarino M. & Bernasconi C. (2003) Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients Leukemia 17, 2107-2112.
2. Bernasconi P., Boni M., Cavigliano P. M., Calatroni S., Giardini I., Rocca B., Zappatore R., Dambruoso I. & Caresana M. (2006) Clinical relevance of cytogenetics in myelodysplastic syndromes. Annals New York Academy of Sciences 1089, 395-410.
3. Bernasconi P., Klersy C., Boni M., Cavigliano P. M., Calatroni S., Giardini I., Rocca B., Zappatore R., Caresana M., Dambruoso I., Lazzarino M. & Bernasconi C. (2007) World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. British Journal of Haematology 137, 193-205.
4. Cherry A. M., Brockman S. R., Paternoster S. F., Hicks G. A., Neuberg D., Higgins R. R., Bennett J. M., Greenberg P. L., Miller K., Tallman M. S., Rowe J. & Dewald G. W. (2003) Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome an Eastern Cooperative Oncology Group (ECOG) study. Leukemia Research 27, 1085-1090.
5. Guralnik J. M., Eisenstaedt R. S., Ferrucci L., Klein H. G. & Woodman R. C. (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104, 2263-2268.
6. Guralnik J. M., Erschler W. B., Schrier S. L. & Picozzi V. J. (2005) Anemia in the elderly: a public health crisis in hematology. Hematology American Society of Hematology Education Program, 528-532.
7. Joosten E. (2004) Strategies for the laboratory diagnosis of some common causes of anemia in elderly patients. Gerontology 50, 49-56.
8. Kao J., McMillan A. & Greenberg P. (2008) International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes. American Journal of Hematology 83, 765-770.
9. Ketterling R. P., Wyatt W. A., Van Wier S. A., Law M., Hodnefield J. M., Hanson C. A. & Dewald G. W. (2002) Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. Leukemia Research 26, 235-240.
10. Nimer S. D. (2008) Myelodysplastic syndromes. Blood 111, 4841-4851.
11. Rigolin G. M., Bigoni R., Milani R., Cavazzini F., Roberti M. G., Bardi A., Agostini P., Della Porta M., Tieghi A., Piva N., Cuneo A. & Castoldi G. (2001) Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia 15, 1841-1847.
12. Romeo M., Chauffaille M., Silva M., Bahia D. M. M. & Kerbauy J. (2002) Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients. Leukemia Research 26, 993-996.
13. Sekeres M., Schoonen M., Kantarjian H., List A., Fryzek J., Paquette R. & Maciejewski J. P. (2008) Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. Journal of the National Cancer Institute 100, 1542-1551.
14. Sole F., Luño E., Sanzo C., Espinet B., Sanz G. F., Cervera J., Calasanz M. J., Cigudosa J. C., Milla F., Ribera J. M., Bureo E., Martin M. L., Arranz E. & Florensa L. (2005) Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 90, 1168-1178.
15. Steensma D. P. & List A. F. (2005) Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clinic Proceedings 80, 681-698.
16. Steensma D. P. & Tefferi A. (2007) Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clinic Proceedings 82, 958-966.
17. Steensma D. P., Dewald G. W., Hodnefield J. M., Tefferi A. & Hanson C. A. (2003) Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leukemia Research 27, 235-242.